SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-043600
Filing Date
2011-02-23
Accepted
2011-02-23 16:18:21
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1089087
2 CONSENT OF ODENBURG, OLLAKKO, MURANISHI & CO. LLP dex231.htm EX-23.1 2162
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 5964
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 5930
5 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2427
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2464
7 GRAPHIC g148945g30i53.jpg GRAPHIC 36373
  Complete submission text file 0001193125-11-043600.txt   1159843
Mailing Address 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM CA 92807
Business Address 1300 NORTH KELLOGG DRIVE SUITE D ANAHEIM CA 92807 714-820-4500
QUESTCOR PHARMACEUTICALS INC (Filer) CIK: 0000891288 (see all company filings)

IRS No.: 330476164 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14758 | Film No.: 11632421
SIC: 2834 Pharmaceutical Preparations